Florida Blue Launches New Oncology Care Model for MyBlue Members in Partnership With Sanitas Medical Centers and The Oncology Institute
Florida Blue Launches New Oncology Care Model for MyBlue Members in Partnership With Sanitas Medical Centers and The Oncology Institute
Florida Blue launches an oncology care model for myBlue members, enhancing access to personalized cancer treatment in Florida.
Quiver AI Summary
Florida Blue has announced the launch of a new oncology care model aimed at enhancing access to high-quality cancer treatment for its myBlue members in select areas of Florida. This collaborative program, developed with Sanitas Medical Centers and The Oncology Institute (TOI), provides personalized, evidence-based treatment plans and supports seamless communication between oncologists and primary care providers. The initiative focuses on patient-centered care by addressing not only medical needs but also the overall health and mental well-being of patients and their families. With the program's goal of transforming cancer care delivery, Florida Blue emphasizes its commitment to making healthcare more affordable and accessible. The myBlue plan is available for individual enrollment during the current Marketplace open enrollment period, which ends on January 15.
Potential Positives
- Florida Blue has launched a new comprehensive oncology care model aimed at providing faster access to high-quality cancer care for its myBlue members.
- This program was developed in collaboration with trusted partners, Sanitas Medical Centers and The Oncology Institute, enhancing the company's network and service offerings.
- The initiative emphasizes personalized, evidence-based treatment plans, improving the overall patient experience during a critical time.
- Florida Blue's commitment to making affordable health care easier and more accessible is clearly articulated, which may enhance its reputation and trust among current and potential members.
Potential Negatives
- The announcement does not provide specific details on how this new oncology care model will address the challenges faced by cancer patients or any metrics for success, which may raise concerns about its effectiveness.
- While the program aims to provide faster access to care, there is no indication of how it will handle potential increases in patient volume or demand, which could strain resources and affect care quality.
- The reliance on a joint venture with Sanitas and The Oncology Institute may present risks regarding accountability and the quality of care delivered, as it introduces multiple stakeholders into the patient care process.
FAQ
What is the new oncology care model by Florida Blue?
The new oncology care model by Florida Blue provides myBlue members faster access to high-quality cancer care through a collaborative approach with The Oncology Institute and Sanitas Medical Centers.
Who can access the new oncology care program?
This program is available to myBlue members diagnosed with cancer in select areas in Florida, with potential expansion in the future.
How does the oncology care model improve patient experience?
The model enhances patient experience by ensuring seamless communication and coordination between primary care providers and oncologists, prioritizing personalized care plans.
What types of services does The Oncology Institute offer?
TOI provides specialized, value-based cancer care, including clinical trials, transfusions, and other advanced healthcare services across its multiple locations in Florida.
How can individuals enroll in the myBlue health plan?
Individuals can enroll in the myBlue health plan during the Marketplace open enrollment period or any time if eligible for a special enrollment.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOI Insider Trading Activity
$TOI insiders have traded $TOI stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here's a breakdown of recent trading of $TOI stock by insiders over the last 6 months:
- BRAD HIVELY has traded it 2 times. They made 2 purchases, buying 300,000 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TOI Hedge Fund Activity
We have seen 14 institutional investors add shares of $TOI stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CINCINNATI INSURANCE CO added 1,334,545 shares (+190.8%) to their portfolio in Q3 2024
- TIFF ADVISORY SERVICES, LLC added 1,214,200 shares (+85.6%) to their portfolio in Q3 2024
- KENT LAKE CAPITAL LLC added 563,287 shares (+47.5%) to their portfolio in Q2 2024
- ELEMENT POINTE ADVISORS, LLC removed 199,026 shares (-100.0%) from their portfolio in Q2 2024
- CITADEL ADVISORS LLC removed 178,367 shares (-66.1%) from their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC removed 169,400 shares (-49.9%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 109,207 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
JACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) --
Florida Blue
, the state's leading health insurer, has launched a new comprehensive oncology care model designed to provide faster access to high-quality cancer care for its myBlue members. This patient-centric program, jointly developed by Florida Blue,
Sanitas Medical Centers
, and
The Oncology Institute
(TOI), is available in select areas across Florida and may grow over time to reach more communities in the state.
The Oncology Institute, one of Florida Blue's trusted in-network providers and the leading value-based oncology group in the U.S., offers high-quality cancer care in 14 locations in Central and South Florida. Sanitas Medical Centers provides value-based, comprehensive primary care for nearly half a million Florida Blue members, through their 60 Florida Blue | Sanitas Medical Center locations across Florida.
Through this new program, myBlue members diagnosed with cancer will be quickly connected with their own TOI oncology team, which will develop personalized, evidence-based treatment plans based on the patients' needs and preferences and will partner with their Sanitas primary care provider to actively support each patient's overall health and mental well-being. This collaborative approach ensures seamless communication and coordination between primary care physicians, oncologists and patients and their family members for more comprehensive and integrated care.
"We are committed to making affordable health care easier and more accessible for our members and our patients," said Elana Schrader, senior vice president, Health Care Services at Florida Blue, and president of GuideWell Health. "This program is an example of how we're transforming the system to deliver value-based care solutions that improve health outcomes and help keep care more affordable. Together with The Oncology Institute and Sanitas, we're able to begin offering myBlue members rapid access to high-quality cancer care, while also empowering the Sanitas primary care team to manage their overall health and well-being during a critical and often stressful time for patients and their families."
Dr. Raul Daza, chief medical officer for Sanitas, added, "We are confident that through our collaboration with The Oncology Institute our patients will have a better overall care experience and clearer communications as they deal with a disease state that can be challenging and complicated to understand. By partnering with TOI, we are taking proactive steps toward providing the support cancer patients require, which can also include other physical, mental and social needs that are critical to help them comply with their treatment. We believe this partnership will set a new standard for oncology care."
myBlue is a popular Florida Blue health insurance plan for individuals and families who buy their own coverage (not provided by employer group coverage) designed to provide access to affordable and convenient health care through a network of trusted providers, like Sanitas Medical Centers. As an HMO plan, it is centered around the member and the primary care doctor who coordinates all of the patient's health care needs.
Individuals who are not currently myBlue members can enroll during the current Marketplace open enrollment period which ends on Jan. 15, or anytime during the year if they qualify for a special enrollment. For more information, please visit
FloridaBlue.com/MarketplaceEnrollment
or call 1-800-876-2227.
About Florida Blue
Florida Blue, the leading health insurer in Florida, has been providing health solutions to residents of Florida for more than 80 years. Driven by its mission of helping people and communities achieve better health, the company serves more than six million members and all 67 Florida counties. Headquartered in Jacksonville, Fla., with more than 9,000 employees, it is an independent licensee of the Blue Cross Blue Shield Association.
For additional information visit
. For the latest news and content, visit the
Florida Blue Newsroom
, and follow Florida Blue on
Facebook
,
LinkedIn
, and Instagram @Florida.Blue; and X (formerly Twitter) @FLBlue.
About Florida Blue | Sanitas Medical Centers
Sanitas Medical Centers is a joint venture between two leading health care organizations – GuideWell Mutual Holding Company and Organización Sanitas Internacional, now under the Keralty brand. GuideWell is a U.S.-based not-for-profit mutual holding company and the parent to a family of forward-thinking companies focused on transforming health care. Keralty is a leading multinational health organization serving more than 10.5 million people with presence in the United States, Colombia, Middle East, Mexico, Brazil, Spain, Peru, Venezuela, Philippines, Dominican Republic and Puerto Rico. The companies are collaborating to expand access to high quality and culturally relevant health care in the United States. Find out more at
.
About GuideWell
GuideWell comprises Florida's Blue Cross Blue Shield plan,
Florida Blue
, which is the leading health insurer in Florida;
Triple-S Management
, Puerto Rico's Blue Cross Blue Shield plan and a leading health care services company on the island;
GuideWell Health
, a portfolio of integrated care delivery organizations providing primary and urgent care at nearly 100 Florida medical centers and affiliate clinics, which includes
Florida Blue | Sanitas Medical Centers
;
Emcara Health,
which partners with primary care providers to extend care into the home;
GuideWell Source
, which provides administrative services to federal health care programs; and
WebTPA
, a market leading administrator of self-funded employer health plans. The company holds majority or significant interests in a range of health solutions companies including
Lucet
, a behavioral health care company that provides technology-enabled support to payers, providers, and health plan members.
GuideWell serves 38.5 million people across 50 states, Puerto Rico and the U.S. Virgin Islands, including more than 6 million individuals in Florida.
For additional information visit
. For details regarding the company's community and sustainability efforts, read the
GuideWell Impact Report
. For the latest news and content, visit the
GuideWell Newsroom
, and follow GuideWell on
Facebook
,
LinkedIn
, Instagram @LifeAtGuideWell, and X @_GuideWell.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit
.
Media
The Oncology Institute, Inc.
Daniel Virnich, MD
danielvirnich@theoncologyinstitute.com
(562) 735-3226 x 81125
Revive
Michael Petrone
mpetrone@reviveagency.com
(615) 760-4542
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com